Improvement of an ultrasensitive human immunodeficiency virus type 1 real-time reverse transcriptase-polymerase chain reaction targeting the long terminal repeat region. 2010

Anke Edelmann, and Ulrich Kalus, and Anke Oltmann, and Angela Stein, and Anett Unbehaun, and Christian Drosten, and Detlev H Krüger, and Jörg Hofmann
Institute of Virology Helmut-Ruska-Haus, Charité University Medicine Berlin, Berlin, Germany. anke.edelmann@charite.de

BACKGROUND Human immunodeficiency virus Type 1 (HIV-1) assays applying nucleic acid testing (NAT) rely on HIV-1 sequence-specific primers and probes. Their hybridization can be limited or abolished by genetic polymorphisms occurring in the target sequence. METHODS Blood donations are routinely tested for HIV-1/2 antibodies and for HIV-1 RNA in our blood transfusion unit. Recently, HIV-1 RNA was undetectable with an established in-house real-time long terminal repeat (LTR) reverse transcriptase-polymerase chain reaction (RT-PCR) in two cases, whereas serologic assays were positive. The reason for this discrepancy was elucidated by sequencing of the NAT target region in the respective single donations. An improved primer was designed and tested on HIV-1 reference panels and blood donations to ensure reliable detection of HIV-1 RNA. RESULTS Direct sequencing of the target region, isolated from samples of two unrelated HIV-positive blood donors, revealed one and four mismatches in the hybridization domain of the forward primer, respectively. Both viruses belong to HIV-1 Subtype B. LTR RT-PCR with an additional forward primer was suitable for all strains of HIV-1 tested with high sensitivity. CONCLUSIONS Surveillance of HIV-1 genetic diversity is essentially required to continually evaluate its impact on performance of diagnostic and patient monitoring assays.

UI MeSH Term Description Entries
D008297 Male Males
D001782 Blood Donors Individuals supplying blood or blood components for transfer to histocompatible recipients. Blood Donor,Donor, Blood,Donors, Blood
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000914 Antibodies, Viral Immunoglobulins produced in response to VIRAL ANTIGENS. Viral Antibodies
D012367 RNA, Viral Ribonucleic acid that makes up the genetic material of viruses. Viral RNA
D012680 Sensitivity and Specificity Binary classification measures to assess test results. Sensitivity or recall rate is the proportion of true positives. Specificity is the probability of correctly determining the absence of a condition. (From Last, Dictionary of Epidemiology, 2d ed) Specificity,Sensitivity,Specificity and Sensitivity
D014644 Genetic Variation Genotypic differences observed among individuals in a population. Genetic Diversity,Variation, Genetic,Diversity, Genetic,Diversities, Genetic,Genetic Diversities,Genetic Variations,Variations, Genetic
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human
D015658 HIV Infections Includes the spectrum of human immunodeficiency virus infections that range from asymptomatic seropositivity, thru AIDS-related complex (ARC), to acquired immunodeficiency syndrome (AIDS). HTLV-III Infections,HTLV-III-LAV Infections,T-Lymphotropic Virus Type III Infections, Human,HIV Coinfection,Coinfection, HIV,Coinfections, HIV,HIV Coinfections,HIV Infection,HTLV III Infections,HTLV III LAV Infections,HTLV-III Infection,HTLV-III-LAV Infection,Infection, HIV,Infection, HTLV-III,Infection, HTLV-III-LAV,Infections, HIV,Infections, HTLV-III,Infections, HTLV-III-LAV,T Lymphotropic Virus Type III Infections, Human

Related Publications

Anke Edelmann, and Ulrich Kalus, and Anke Oltmann, and Angela Stein, and Anett Unbehaun, and Christian Drosten, and Detlev H Krüger, and Jörg Hofmann
December 2004, The Journal of infectious diseases,
Anke Edelmann, and Ulrich Kalus, and Anke Oltmann, and Angela Stein, and Anett Unbehaun, and Christian Drosten, and Detlev H Krüger, and Jörg Hofmann
June 2007, Journal of neurovirology,
Anke Edelmann, and Ulrich Kalus, and Anke Oltmann, and Angela Stein, and Anett Unbehaun, and Christian Drosten, and Detlev H Krüger, and Jörg Hofmann
January 2010, Methods in molecular biology (Clifton, N.J.),
Anke Edelmann, and Ulrich Kalus, and Anke Oltmann, and Angela Stein, and Anett Unbehaun, and Christian Drosten, and Detlev H Krüger, and Jörg Hofmann
November 2006, Diagnostic microbiology and infectious disease,
Anke Edelmann, and Ulrich Kalus, and Anke Oltmann, and Angela Stein, and Anett Unbehaun, and Christian Drosten, and Detlev H Krüger, and Jörg Hofmann
June 2006, Plastic and reconstructive surgery,
Anke Edelmann, and Ulrich Kalus, and Anke Oltmann, and Angela Stein, and Anett Unbehaun, and Christian Drosten, and Detlev H Krüger, and Jörg Hofmann
February 1996, Biological chemistry Hoppe-Seyler,
Anke Edelmann, and Ulrich Kalus, and Anke Oltmann, and Angela Stein, and Anett Unbehaun, and Christian Drosten, and Detlev H Krüger, and Jörg Hofmann
August 2009, Journal of medical virology,
Anke Edelmann, and Ulrich Kalus, and Anke Oltmann, and Angela Stein, and Anett Unbehaun, and Christian Drosten, and Detlev H Krüger, and Jörg Hofmann
November 1993, Journal of clinical microbiology,
Anke Edelmann, and Ulrich Kalus, and Anke Oltmann, and Angela Stein, and Anett Unbehaun, and Christian Drosten, and Detlev H Krüger, and Jörg Hofmann
May 2003, The Journal of urology,
Anke Edelmann, and Ulrich Kalus, and Anke Oltmann, and Angela Stein, and Anett Unbehaun, and Christian Drosten, and Detlev H Krüger, and Jörg Hofmann
October 2006, Biomedica : revista del Instituto Nacional de Salud,
Copied contents to your clipboard!